FDA-approved oral GLP-1s match injectables in weight loss effectiveness with similar side effects and health benefits. There are differences, however.

With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity ...

From nausea and exhaustion to emotional shifts and social awkwardness, people on GLP-1 medications are sharing the side effects they didn't expect — and rarely see talked about. View Entire Post › ...

GLP-1 medications are approved for several conditions, including Type 2 diabetes, obesity, cardiovascular disease, chronic ...

The discussion surrounding GLP-1 medications needs to change to one that emphasizes science-based research and compassion.

Participating Medicare Part D plans can officially begin covering weight-loss treatment in 2027. The initiative falls under CMS’ voluntary “Better Approaches to Lifestyle and Nutrition for ...

LMNT reports that GLP-1 medications for obesity and diabetes may lead to electrolyte imbalances, highlighting hydration ...

Acute pancreatitis is linked to the development of gallstones, which are listed as a side effect with GLP-1 drugs. Ahmed said ...

The FDA is requesting that manufacturers of three GLP-1 receptor agonists remove information on risk for suicidal ideation and behavior from their labels following an investigation, the agency stated ...

The use of GLP-1 receptor antagonist therapy has led to a greater reduction in colorectal cancer incidence than has been ...